- Drug therapy of overactive bladder - What is coming next?
-
Andersson
- KMID: 2344109
- Korean J Urol.
- 2015 Oct;56(10):673-679.
- doi: 10.4111/kju.2015.56.10.673
After the approval and introduction of mirabegron, tadalafil, and botulinum toxin A for treatment of lower urinary tract symptoms/overactive bladder, focus of interest has been on their place in therapy... -
- CITED
-
- Close
- SHARE
-
- Close
- Presence of Fusion in Albinism after Strabismus Surgery Augmented with Botulinum Toxin (Type A) Injection
-
Tavakolizadeh S, Farahi A
- KMID: 1705431
- Korean J Ophthalmol.
- 2013 Aug;27(4):308-310.
- doi: 10.3341/kjo.2013.27.4.308
It is commonly accepted that albino patients with strabismus rarely achieve binocularity and depth perception after strabismus surgery. The presence of retino-geniculo-cortical misrouting, a hallmark of the visual system in... -
- CITED
-
- Close
- SHARE
-
- Close
- Secondary and tertiary treatments for multiple sclerosis patients with urinary symptoms
-
Tracey JM, Stoffel JT
- KMID: 2451396
- Investig Clin Urol.
- 2016 Nov;57(6):377-383.
- doi: 10.4111/icu.2016.57.6.377
Multiple sclerosis patients with refractory urinary symptoms after treatment with behavioral therapy and medications still have treatment options. Prior to starting treatments, baseline symptoms should be assessed and treatment goals... -
- CITED
-
- Close
- SHARE
-
- Close
